Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer ; volume:15 ; number:1 ; day:8 ; month:4 ; year:2015 ; pages:1-15 ; date:12.2015
BMC cancer ; 15, Heft 1 (8.4.2015), 1-15, 12.2015
- Urheber
-
Larsen, Sarah L.
- Beteiligte Personen und Organisationen
-
Yde, Christina W.
Laenkholm, Anne-Vibeke
Rasmussen, Birgitte B.
Duun-Henriksen, Anne Katrine
Bak, Martin
Lykkesfeldt, Anne E.
Kirkegaard, Tove
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1210-4
- URN
-
urn:nbn:de:1111-2016110621190
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Larsen, Sarah L.
- Yde, Christina W.
- Laenkholm, Anne-Vibeke
- Rasmussen, Birgitte B.
- Duun-Henriksen, Anne Katrine
- Bak, Martin
- Lykkesfeldt, Anne E.
- Kirkegaard, Tove
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Aurora kinases as targets in drug-resistant neuroblastoma cells
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
Advanced materials for corrosion resistant coatings
Endovascular Baroreflex Amplification for Resistant Hypertension
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Aurora kinases as targets in drug-resistant neuroblastoma cells
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
Advanced materials for corrosion resistant coatings
Endovascular Baroreflex Amplification for Resistant Hypertension
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Aurora kinases as targets in drug-resistant neuroblastoma cells
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
Advanced materials for corrosion resistant coatings